Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Mankind Pharma Shares Jump Nearly 8% After Q2 Profit Rises 39%

    17 hours ago

    Mankind Pharma's September-quarter performance was supported by 15.9% growth in domestic pharmaceutical revenue, excluding consumer healthcare, to Rs 3,428 crore. However, performance in consumer healthcare will remain key monitorable.
    Click here to Read More
    Previous Article
    Novo Nordisk Loses US Ruling Over Eli Lilly Obesity Drug Ads
    Next Article
    Sona BLW Shares Jump Over 6% After Q2 Profit Rises 29%; BEV Revenue Surges 129%

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment